GT201200259A - Hidrato del hidrocloruro de agomelatina y preparación de éste - Google Patents

Hidrato del hidrocloruro de agomelatina y preparación de éste

Info

Publication number
GT201200259A
GT201200259A GT201200259A GT201200259A GT201200259A GT 201200259 A GT201200259 A GT 201200259A GT 201200259 A GT201200259 A GT 201200259A GT 201200259 A GT201200259 A GT 201200259A GT 201200259 A GT201200259 A GT 201200259A
Authority
GT
Guatemala
Prior art keywords
hydrochloride
preparation
agomelatin
hydrocloride
high purity
Prior art date
Application number
GT201200259A
Other languages
English (en)
Inventor
Shan Hanbin
Yuan Zhedong
Zhu Xueyan
Zhang Peng
Pan Hongjuan
Yu Xiong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44599556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200259(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201200259A publication Critical patent/GT201200259A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Abstract

SE PROPORCIONA UN HIDRATO DEL HIDROCLORURO DE AGOMELATINA, PREPARACIÓN, USO Y COMPOSICIÓN FARMACÉUTICA DEL MISMO. DICHO HIDRATO OBTENIDO MEDIANTE EL PRESENTE MÉTODO TIENE UNA SOLUBILIDAD SIGNIFICATIVAMENTE AUMENTADA QUE LA AGOMELATINA Y POR ELLO, ES MÁS ADECUADA PARA FABRICAR FORMULACIONES FARMACÉUTICAS. USANDO EL PRESENTE MÉTODO, SE PUEDE OBTENER UNA PUREZA ELEVADA MEDIANTE UN PROCESO SIMPLE.
GT201200259A 2010-03-17 2012-09-17 Hidrato del hidrocloruro de agomelatina y preparación de éste GT201200259A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010126254XA CN102190594A (zh) 2010-03-17 2010-03-17 阿戈美拉汀氯化氢水合物及其制备方法

Publications (1)

Publication Number Publication Date
GT201200259A true GT201200259A (es) 2013-12-03

Family

ID=44599556

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201200259A GT201200259A (es) 2010-03-17 2012-09-17 Hidrato del hidrocloruro de agomelatina y preparación de éste

Country Status (36)

Country Link
US (1) US8729131B2 (es)
EP (1) EP2547649B1 (es)
JP (1) JP5634532B2 (es)
KR (1) KR101406727B1 (es)
CN (2) CN102190594A (es)
AP (1) AP2012006492A0 (es)
AU (1) AU2011229618B2 (es)
BR (1) BR112012023317B1 (es)
CA (1) CA2792417C (es)
CL (1) CL2012002540A1 (es)
CR (1) CR20120462A (es)
CU (1) CU20120137A7 (es)
CY (1) CY1116086T1 (es)
DK (1) DK2547649T3 (es)
EA (1) EA022067B1 (es)
EC (1) ECSP12012155A (es)
ES (1) ES2530772T3 (es)
GE (1) GEP20156231B (es)
GT (1) GT201200259A (es)
HK (1) HK1177451A1 (es)
HR (1) HRP20150071T1 (es)
IL (1) IL221782A (es)
MA (1) MA34055B1 (es)
ME (1) ME02054B (es)
MX (1) MX2012010541A (es)
NI (1) NI201200140A (es)
NZ (1) NZ602450A (es)
PE (1) PE20130013A1 (es)
PL (1) PL2547649T3 (es)
PT (1) PT2547649E (es)
RS (1) RS53815B1 (es)
SG (1) SG183868A1 (es)
SI (1) SI2547649T1 (es)
TN (1) TN2012000435A1 (es)
UA (1) UA105425C2 (es)
WO (1) WO2011113362A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2551257A1 (en) * 2011-07-28 2013-01-30 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of agomelatine with co-crystal-formers
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN102702041B (zh) * 2012-05-14 2013-08-14 上海右手医药科技开发有限公司 阿戈美拉汀苯磺酸类复合物及其制备方法
KR20150020191A (ko) * 2012-05-14 2015-02-25 상하이 라이트핸드 팜테크 주식회사 아고멜라틴 산기 복합체와 그의 제조방법 및 용도
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
CN102718676B (zh) * 2012-06-26 2014-04-09 福建广生堂药业股份有限公司 阿戈美拉汀硫酸盐及其制备方法
WO2014096373A1 (en) 2012-12-21 2014-06-26 Laboratorios Lesvi, S. L. Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2015013865A1 (en) * 2013-07-29 2015-02-05 Les Laboratoires Servier Agomelatine sulfonic acids complexes and preparation thereof
KR101470794B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물
EP3317281B1 (en) 2015-07-02 2020-04-22 Acerta Pharma B.V. Solid forms and formulations of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
US10367757B2 (en) * 2016-08-27 2019-07-30 Nicira, Inc. Extension of network control system into public cloud

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SK6182003A3 (en) * 2000-10-30 2004-03-02 Teva Pharma Crystalline and solvated forms of ondansetrone hydrochloride and preparation thereof
FR2890562B1 (fr) * 2005-09-09 2012-10-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime
FR2899472B1 (fr) * 2006-04-07 2008-09-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee
FR2934859B1 (fr) 2008-08-05 2010-08-13 Servier Lab Nouveau procede de synthese de l'agomelatine
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms

Also Published As

Publication number Publication date
CA2792417C (en) 2015-11-24
BR112012023317B1 (pt) 2021-07-06
NZ602450A (en) 2014-12-24
KR20120128712A (ko) 2012-11-27
EA022067B1 (ru) 2015-10-30
ME02054B (me) 2015-05-20
GEP20156231B (en) 2015-01-26
US20130005820A1 (en) 2013-01-03
JP2013522241A (ja) 2013-06-13
US8729131B2 (en) 2014-05-20
NI201200140A (es) 2012-11-09
CL2012002540A1 (es) 2013-01-11
UA105425C2 (ru) 2014-05-12
EA201201294A1 (ru) 2013-04-30
IL221782A (en) 2017-11-30
EP2547649B1 (en) 2014-11-19
BR112012023317A2 (pt) 2016-05-24
JP5634532B2 (ja) 2014-12-03
HRP20150071T1 (en) 2015-02-27
PL2547649T3 (pl) 2015-04-30
KR101406727B1 (ko) 2014-06-13
ECSP12012155A (es) 2012-12-28
CN102958911B (zh) 2015-11-25
RS53815B1 (en) 2015-06-30
AP2012006492A0 (en) 2012-10-31
SI2547649T1 (sl) 2015-03-31
MA34055B1 (fr) 2013-03-05
DK2547649T3 (en) 2015-03-02
PE20130013A1 (es) 2013-01-26
CN102190594A (zh) 2011-09-21
EP2547649A4 (en) 2013-09-04
CN102958911A (zh) 2013-03-06
MX2012010541A (es) 2012-10-05
CY1116086T1 (el) 2017-02-08
CA2792417A1 (en) 2011-09-22
TN2012000435A1 (en) 2014-01-30
AU2011229618B2 (en) 2014-05-22
AU2011229618A1 (en) 2012-09-27
ES2530772T3 (es) 2015-03-05
PT2547649E (pt) 2014-12-29
HK1177451A1 (zh) 2013-08-23
EP2547649A1 (en) 2013-01-23
WO2011113362A1 (en) 2011-09-22
SG183868A1 (en) 2012-10-30
CR20120462A (es) 2012-10-05
CU20120137A7 (es) 2012-11-15

Similar Documents

Publication Publication Date Title
GT201200259A (es) Hidrato del hidrocloruro de agomelatina y preparación de éste
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
DOP2014000133A (es) Triazolopiridinas sustituidas
BR112012028395A2 (pt) processo para preparar ditiina-tetracarboxi-diimidas
ECSP13013011A (es) Triazolopiridinas
CL2017000293A1 (es) Compuestos derivados de benzofurano sustituido en posición 6 por un radical que contiene boro; composición farmacéutica que los comprende; uso en el tratamiento de la hepatitis c (divisional del cl 393-2014)
ECSP13012438A (es) Proceso para preparar compuestos antivirales
SV2018005760A (es) Derivados de aminotiazol utiles como agentes antiviricos
CO6731092A2 (es) Nueva forma de administración de inhibidor de encefalinasa
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
BR112012009310A2 (pt) composto, e, composição farmacêutica
CL2011001405A1 (es) Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
IN2013MU00711A (es)
BR112016001876A2 (pt) composto de benzoxaborol tricíclico, método de preparação e uso do mesmo
MY189459A (en) Anti-cancer agents and preparation thereof
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
BR112013031575A2 (pt) composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto.
CL2016000787A1 (es) Composición farmacéutica en forma de comprimido que comprende atazanavir y cobicistat; procedimiento de preparación; y uso de la composición para preparar un medicamento útil para tratar la infección por el virus de inmunodeficiencia humana (vih).
IN2013MU01985A (es)
NI201200141A (es) Hidrato del hidrobromuro de agomelatina y preparación de éste
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
BR112016028083A2 (pt) Composição oral farmacêutica de isotretinoina e seu processo de preparação
BR112015031820A2 (pt) composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos